Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

5,737 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Association of methotrexate polyglutamates concentration with methotrexate efficacy and safety in patients with rheumatoid arthritis treated with predefined dose: results from the MIRACLE trial.
Tamai H, Ikeda K, Miyamoto T, Taguchi H, Kuo CF, Shin K, Hirata S, Okano Y, Sato S, Yasuoka H, Kuwana M, Ishii T, Kameda H, Kojima T, Nishi Y, Mori M, Miyagishi H, Toshima G, Sato Y, Tsai WC, Takeuchi T, Kaneko Y; MIRACLE Study Group. Tamai H, et al. Among authors: takeuchi t. Ann Rheum Dis. 2025 Jan;84(1):41-48. doi: 10.1136/ard-2024-226350. Epub 2025 Jan 2. Ann Rheum Dis. 2025. PMID: 39874232 Clinical Trial.
Efficacy, Safety, Pharmacokinetics, and Immunogenicity of ABBV-154 in Adults With Glucocorticoid-Dependent Polymyalgia Rheumatica: A Phase 2, Randomized, Double-Blind, Placebo-Controlled Trial.
Spiera RF, Devauchelle-Pensec V, Owen CE, Díaz-González F, Takeuchi T, Drescher E, Anderson J, Arikan D, D'Cunha R, Parmentier J, Kruzikas DT, Zhao W, Yang Y, Stellpflug K, Buttgereit F. Spiera RF, et al. Among authors: takeuchi t. Arthritis Rheumatol. 2025 Jan 27. doi: 10.1002/art.43129. Online ahead of print. Arthritis Rheumatol. 2025. PMID: 39866124
Efficacy and safety of first-line targeted synthetic DMARDs in rheumatoid arthritis patients with chronic kidney disease.
Yoshimura Y, Yamanouchi M, Koizumi R, Mizuno H, Oba Y, Kurihara S, Suwabe T, Tsunoda S, Kishioka A, Takeuchi T, Tanimizu H, Kamido H, Yoshimoto M, Sugimoto H, Ikuma D, Tanaka K, Inoue N, Sekine A, Hasegawa E, Wada T, Ubara Y, Sawa N. Yoshimura Y, et al. Among authors: takeuchi t. Rheumatology (Oxford). 2025 Jan 25:keaf050. doi: 10.1093/rheumatology/keaf050. Online ahead of print. Rheumatology (Oxford). 2025. PMID: 39862405
5,737 results